FDA NDC Directory · JSON-LD · Markdown

Mesalamine

NDC 0781-2791 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE

Labeler / ManufacturerSandoz Inc
Marketing categoryAbbreviated NDA (generic) · App ANDA219997
Dosage form / routeCAPSULE, EXTENDED RELEASE · ORAL
Active ingredientsMESALAMINE (250 mg/1)
Marketing started20260721
Package count1

External sources

Source: openFDA. Public-domain (CC0).